Tag: GSK
GSK: the acquisition of Bellus Health is finalized
(CercleFinance.com) – GSK announced on Wednesday that it has completed the acquisition of Bellus Health, a Canadian biopharmaceutical company specializing in the treatment of chronic refractory cough (CCR), for an…
GSK: Fast Track designation for an experimental vaccine
(CercleFinance.com) – GSK announced today that the United States Food and Drug Administration (FDA) has granted Fast Track designation to its investigational vaccine against Neisseria gonorrhoeae (NgG). The vaccine candidate…
GSK: Expanded indication for Shingrix in Japan
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
GSK: CHMP recommends the anti-anaemic aprodustat
(CercleFinance.com) – GSK announced on Monday that the Committee for Medicinal Products for Human Use (CHMP) has recommended the marketing of daprodustat for the treatment of anemia linked to chronic…
GSK: FDA extends review of cancer drug momelotinib
(CercleFinance.com) – GSK announced Friday that the FDA has decided to extend the review period of the application for approval of momelotinib, an experimental treatment for myelofibrosis, a rare blood…
GSK: Court ruling favorable to Canada, the action is rising
(CercleFinance.com) – GSK welcomed on Friday the rejection by Canadian justice of a class action petition that had been presented in the context of the Zantac case, which supported the…
In Saint-Amand-les-Eaux, the GSK vaccine factory bears witness to the vitality of the market
A production line, within the GlaxoSmithKline (GSK) factory, in Saint-Amand-les-Eaux (North), on December 3, 2020. FRANCOIS LO PRESTI / AFP “ Do you want to pursue a career in a…
GSK: positive phase III data in urinary tract infections
(Communicated) (CercleFinance.com) – GSK reports positive results from the pivotal Phase III EAGLE-2 and EAGLE-3 trials for gepotidacin, an investigational oral antibiotic with a novel mechanism of action for uncomplicated…
GSK: Partnership with PathAI in NASH
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
GSK: Enters into an exclusive license agreement with Scynexis
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
GSK: Success of a phase 3 trial with Jemperli
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
GSK: Strategic agreement with Cytel in clinical trials
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…